E Fund Management (HK)’s AstraZeneca AZN Stock Holding History

E Fund Management (HK)’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$18.8K	Buy	+99	New	+$18.6K	0.01%	328
2025 Q4	–	Sell	-233	Closed	-$35.8K	–	398
2025 Q3	$35.8K	Buy	233 +137	+143%	+$20.7K	0.02%	129
2025 Q2	$13.3K	Hold	96	–	–	0.01%	127
2025 Q1	$14K	Buy	96 +72	+300%	+$10.4K	0.01%	133
2024 Q4	$3K	Buy	24 +22	+1,100%	+$3.08K	﹤0.01%	140
2024 Q3	$0	Hold	2	–	–	﹤0.01%	125
2024 Q2	$0	Buy	+2	New	+$301	﹤0.01%	103

Other funds holding AZN

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

CDDEC

Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return

MIF

Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return

ZIC

ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return

E Fund Management (HK)'s AZN Position: Q2 2026 in Review

E Fund Management (HK) opened a new position in AstraZeneca (AZN) in Q2 2026: 99 shares worth $18.8K. The stake represents 0.01% of the portfolio and ranks #328 among its holdings. This is a return to the name: E Fund Management (HK) previously reported a position in AZN as recently as Q3 2025.

E Fund Management (HK) first reported a position in AZN in Q2 2024 and has held it in 7 quarters since. The position peaked at $35.8K in Q3 2025. 421 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

E Fund Management (HK) held 99 shares of AstraZeneca worth $18.8K as of Q2 2026.
AstraZeneca was a new E Fund Management (HK) position in Q2 2026.
AstraZeneca made up 0.01% of E Fund Management (HK)'s portfolio in Q2 2026, its #328 holding.
E Fund Management (HK) first reported a position in AstraZeneca in Q2 2024 and has held it in 7 quarters since.
E Fund Management (HK)'s AstraZeneca position peaked at $35.8K in Q3 2025.
421 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on E Fund Management (HK)'s 13F filing for Q2 2026, filed 22 Jul 2026.